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Abstract:
Background and Aims: Diabetes mellitus type 2 (DM-2) is one of the most recurrent chronic diseases worldwide, it is usually treated with synthetic 
medications, many of which have important repercussions on the patient’s body. For this reason, ethnopharmacology has become more important 
in recent years, because a large number of plant resources origin are used in medicine and are shown as positive effect in the treatment of different 
diseases, including DM-2. Therefore, the aim of this review is to highlight how previous studies are adding to the understanding and knowledge of 
the biological effects reported in Cecropia obtusifolia, a tropical plant included in the Herbal Pharmacopoeia of the United Mexican States (FHEUM), 
which is commonly used to treat DM-2.
Methods: A profound literature review was carried out on C. obtusifolia, focusing on diverse phytochemical, pharmacological, clinical and toxicolog-
ical studies, as well as on some other relevant research findings.
Key results: It is recognized that this species is able to decrease serum glucose, cholesterol and triglyceride levels due to its hypoglycemic and hypo-
lipidemic properties, which has been demonstrated both in animal and human experimental models, attributing these effects to chlorogenic acid and 
isoorientin. These previous reports suggest that C. obtusifolia is a promising candidate for the development of a phytopharmaceutical which could 
be used in the treatment of DM-2.
Conclusions: We provide an updated and complete overview of the phytochemistry, traditional uses, and pharmacological activities of C. obtusifolia. 
Regarding its pharmacological activities, we focus mainly on the hypoglycemic effect of this plant which supports its traditional use in DM-2 control. 
Moreover, the present knowledge was critically assessed to provide some evidence and justifications and propose future research prospects.
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Resumen:
Antecedentes y Objetivos: La diabetes mellitus tipo 2 (DM-2) es una de las enfermedades crónicas recurrentes más comunes, generalmente se trata 
con medicamentos sintéticos, muchos de los cuales tienen importantes repercusiones en el cuerpo del paciente. Por esta razón, la etnofarmacología 
se ha vuelto más importante en los últimos años, porque una gran cantidad de recursos de origen vegetal son utilizados en medicina y muestran un 
efecto positivo en el tratamiento de diferentes enfermedades, incluyendo DM-2. Por lo tanto, el objetivo de esta revisión es destacar cómo los estu-
dios previos se suman a la comprensión y el conocimiento de los efectos biológicos informados en Cecropia obtusifolia, una planta tropical incluida 
en la Farmacopea Herbolaria de los Estados Unidos Mexicanos (FHEUM), comúnmente usada para tratar DM-2.
Métodos: Se realizó una revisión profunda de la literatura sobre C. obtusifolia, centrándose en diversos estudios fitoquímicos, farmacológicos, clíni-
cos y toxicológicos, así como en otros hallazgos relevantes de investigación.
Resultados clave: Se reconoce que esta especie es capaz de disminuir los niveles séricos de glucosa, colesterol y triglicéridos, debido a sus propieda-
des hipoglucémicas e hipolipidémicas reductoras de lípidos, que se han demostrado tanto en modelos experimentales animales como en humanos, 
atribuyendo estos efectos al ácido clorogénico y la isoorienina. Estos informes previos sugieren que C. obtusifolia es un candidato prometedor para 
el desarrollo de un fitofarmacéutico que podría usarse en el tratamiento de DM-2.
Conclusiones: Brindamos una visión general actualizada y completa de la fitoquímica, los usos tradicionales y las actividades farmacológicas de C. 
obtusifolia. En cuanto a sus actividades farmacológicas, nos centramos principalmente en el efecto hipoglucémico de esta planta que apoya su uso 
tradicional en el control de DM-2. Además, el conocimiento actual se evaluó críticamente para proporcionar algunas pruebas y justificaciones y pro-
poner futuras perspectivas de investigación.
Palabras clave: ácido clorogénico, efecto hipoglucémiante, etnofarmacología, plantas medicinales.
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Introduction
Many plant species naturally produce compounds that ex-
ert therapeutic action for humans, so they have been called 
“medicinal plants” since antiquity. It is estimated that 
around 35,000 species that are used for medicinal purpos-
es have been classified worldwide (Ghulam et al., 2017), 
and the World Health Organization (WHO) calculates that 
approximately 80% of the population around the world 
uses medicinal plants for the treatment of diseases (Rive-
ra-Mondragón et al., 2017).
The total floristic wealth of Mexico is constituted of 
23,314 species, placing it in the fourth place in the world 
(Villaseñor, 2016). Of this total, it has been reported that 
around 3000 species of angiosperm plants (approximately 
15% of the total flora) have medicinal properties, i.e., one in 
seven species possesses some curative features (Ocegueda 
et al., 2005; Villaseñor, 2016). For these reasons, scientific 
attention has now been diverted to ethnomedicine, since 
in the last years an increase in demand for natural prod-
ucts from medicinal herbs products has developed, since 
the modern pharmacopoeia includes about 25% of the 
medicines that have been derived from this type of plants 
(Ghulam et al., 2017). For example, in Germany, there are 
two commercial phytopharmaceuticals used for the treat-
ment of diabetes from endemic plants of the American 
continent, which are widely used in traditional Mexican 
medicine. The first one is Hando, which is based on nopal 
(Opuntia streptacantha Lem.) and is manufactured by the 
company Hando Austria. The second phytomedicine is Su-
contral, which is produced from the medicinal plant Copal-
chi (Hintonia latiflora (DC) Bullock), and is manufactured by 
the company Harras Pharma, Munich. (Andrade-Cetto and 
Heinrich, 2005).
Therefore, it is urgent and necessary to conduct 
studies of medicinal plants for the identification and char-
acterization of the active compounds of complex mixtures 
that allow different analytical and biomedical tests to in-
dicate their biological activity (treatment of degenerative 
diseases such as diabetes among others), efficacy, and 
toxicity to prevent side effects. Diverse natural products 
based on medicinal plants (herbal medicines) exist on the 
market, with very little information about their chemical 
composition and pharmacological effects that can have 
adverse effects, different from those expected (positive 
effects on health).
Therefore, this work contains a compilation of dif-
ferent studies carried out in Cecropia obtusifolia Bertol., 
which is widely used for the treatment of diabetes mellitus 
type 2 (DM-2). This disease is characterized by the lack of 
sensitivity to insulin (resistance to insulin) and insufficient 
pancreatic secretion and unability to compensate for these 
alterations (dysfunction of β cells), resulting in hyperinsu-
linemia, hyperlipidemia, hypercholesterolemia, glucose in-
tolerance and hypertension (Ross et al., 2004). Therefore, 
this plant has been widely used in traditional medicine in 
Mexico due to its hypoglycemic and hypolipidemic effects, 
which has led the scientific community to focus efforts to 
elucidate the modes of action of this species in DM-2.
Materials and Methods
A traditional manual search approach was used in which, 
by using keywords, reliable, accurate and up-to-date mate-
rial related to phytochemical, pharmacological, toxicologi-
cal and clinical studies of the medicinal plants, C. obtusifo-
lia, were identified. Searches of scientific reports, books, as 
well as postgraduate theses were done mainly using three 
bibliographic databases (PubMed, Scopus, Web of Science) 
and one full-text database (Google Scholar). Literature was 
categorized, read and analyzed to summarize and synthe-
size some key points, which are discussed to highlight their 
importance and based on this previous knowledge identify/
suggest areas of opportunity for future research.
Results
Importance of medicinal plants in the 
ethnopharmacology
Natural products research is commonly related to the dis-
covery and development of drugs based on ethnobotanical 
information, where the plants have formed the base of so-
phisticated systems of traditional medicine, based on em-
pirical findings, and the knowledge associated to their uses 
has been transmitted for hundreds and thousands of years 
(Buenz et al., 2017) (Fig. 1).
Natural products contain bioactive phytochemicals 
that are becoming increasingly important in foods such as 
Nutraceuticals (NC) (Foster et al., 2005). Therefore, ethno-
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Figure 1: Methodology traditionally used for the identification of medicinal plants through life experiences between generations. Design by J. D. 
Cadena-Zamudio. Based on the adaptation of Buenz et al., 2017.
pharmacological research has focused on obtaining natu-
ral products and generating libraries with them, since they 
have shown a higher success rate compared to the libraries 
obtained by combinatorial chemistry. Each combinatorial 
approach has its own exclusive high-performance coding 
and selection strategy, which leads to different success 
and performance rates between each method (Sukuru et 
al., 2009; Liu et al., 2017). Since the primary and second-
ary metabolites examined and obtained from plants have 
already presumed different biological functions, and al-
though these libraries have fewer compounds than those 
obtained by combinatorial chemistry, the percentage of 
products with biological activity is higher in natural prod-
ucts, which has been corroborated thanks to the use of 
techniques such as high performance like high-through-
put screening (HTS), where the timely detection of natu-
ral products has reported higher rates (Sukuru et al., 2009; 
Harvey et al., 2015; Buenz et al., 2017). This suggests that 
the historical ethnopharmacological uses of plant-based 
drugs can be used as a preliminary screening criterion for 
the identification of bioactive compounds, since natural 
products and their derivatives represent around 50% of the 
total number of drugs in clinical use in the world, being the 
angiosperms 25% of the total; causing a quarter of all med-
ical prescriptions to be formulations based on substances 
derived from plants or synthetic analogues derived from 
natural compounds (Castillo-España et al., 2009).
Unfortunately, the continuous loss of knowledge in 
traditional medicine and biodiversity, as a consequence of 
human population growth, has resulted in the loss of orig-
inal resources (natural sources), which has motivated the 
scientific community to increase efforts to restore and doc-
ument the ethnopharmacological use of natural products 
in the original communities. These tools are of great utility 
for future discovery of new biologically active compounds 
(Martínez-Francés et al., 2015; Buenz et al., 2017).
Species used for the treatment of DM-2
Mexico is considered one of the countries with the great-
est biodiversity in the world; it is estimated that there are 
23,400 vascular plants in this country, of which around 
3000 have medicinal effects (Villaseñor, 2016). Of these 
plant species, 1200 have hypoglycemic activity and are 
used in traditional medicine for treatment with DM-2 (An-
Cadena-Zamudio et al.: Ethnopharmacological studies of Cecropia obtusifolia (Urticaceae)
Acta Botanica Mexicana 126: e1361  |  2019  |  10.21829/abm126.2019.1361 4
drade-Cetto et al., 2010). The reports suggest that the hy-
poglycemic activity is conferred by some kind of secondary 
metabolite that is biosynthesized by these plants (Hernán-
dez-Galicia et al., 2007; Romero-Cerecero et al., 2009; An-
drade-Cetto et al., 2010; Alonso-Castro et al., 2016). The 
chemical and pharmacological evaluations to confirm or 
discard the antidiabetic properties (and/or hypoglycemic 
effect) have been carried out in 5% of these reported spe-
cies only, and the pharmacological mechanism of action 
has been studied in very few of them (Alarcón-Aguilar et 
al., 2002; Ocegueda et al., 2005).
In Mexico, seven species stand out for being widely 
used in traditional medicine to treat DM-2; phytochem-
ical and pharmacological studies exist for all of them, 
proving their activity, both in vivo or in vitro (Pérez et al., 
1984; Román-Ramos et al., 1991; Alarcón-Aguilar et al., 
2002; Andrade-Cetto and Heinrich, 2005). Within this se-
lect group of plants, most of them are now included in 
the Herbal Pharmacopoeia of the United Mexican States 
(FEUM), such as the “nopal” (Opuntia streptacantha) 
and “tronadora” (Tecoma stans (L.) Juss. ex Kunth). Hy-
poglycemic activity of O. streptacantha was demonstrat-
ed in healthy rabbits with temporal hyperglycemia and 
in rabbits with moderate diabetes (Andrade-Cetto and 
Heinrich, 2005). On the other hand, Mellado and Lozoya 
(1985) showed the hypoglycemic effect of T. stans infusion 
through intravenous administration in dogs, and likewise, 
Aguilar-Santamaría et al. (2009) identified antidiabetic ac-
tivities in streptozotocin (STZ) rats, including the inhibition 
of intestinal glucosidase and postprandial antihyperglyce-
mic effects, as well as hypocholesterolemic and hypotri-
glyceridemic effects.
Other plants studied are commonly known in Mex-
ico as “trompetilla” (Bouvardia ternifolia (Cav.) Schltdl.), 
“hierba dorada” (Brickellia veronicifolia (Kunth) A. Gray) 
and “cuajilote” (Parmentiera aculeata (Kunth) Seem.), 
their aqueous extracts showing hypoglycemic activity ad-
ministered to normoglycemic and induced diabetic mice 
(Peréz-Gutiérrez et al., 1998). Similar studies have been 
conducted in Ibervillea sonorae (S. Watson) Greene and 
Parkinsonia aculeata L., species commonly known as 
“wereke” and “retama”, respectively (Alarcón-Aguilar et 
al., 2002, 2005; Hernández-Galicia et al., 2007; Leite et 
al., 2007). Finally, the Urticaceae family has considered its 
wide use of traditional medicine, of which the empirical 
treatment of DM-2 stands out, where the most used for 
this condition are Cecropia peltata L. and Cecropia obtusi-
folia (Giovannini et al., 2016).
Cecropia obtusifolia, geographical distribution 
and traditional use
Cecropia obtusifolia (Fig. 2), a plant of the family Urticace-
ae, popularly known as “guarumbo”, “ghancarro”, “hormi-
guillo”, “chiflon” and “koochlé”, is used in Mexico by the 
traditional healers for DM-2 treatment (Martínez-Toledo 
et al., 2008). This species is originally from Central Amer-
ica and it is distributed from Mexico to northern South 
America; it grows in tropical, warm, semi-warm and tem-
perate climates, from regions bordering the coasts and 
up to 1500 m above sea level. Cecropia obtusifolia grows 
in tropical forests and in secondary vegetation of decid-
uous, subperennial or evergreen forests that have been 
disturbed; sometimes it is associated with xerophilous 
scrub of cacti or cedar, in pasture and in mixed oak-pine 
forest (Argueta et al., 1994; Aguilar et al., 1998; Berg et 
al., 2005). In Mexico, it is distributed on the Mexican Gulf 
slope, from the states of Tamaulipas to Quintana Roo, and 
in the Pacific, from Sinaloa to Chiapas, Puebla, Hidalgo 
and Guanajuato (Argueta et al., 1994; Andrade-Cetto and 
Heinrich, 2005).
The use of C. obtusifolia to treat diabetes was 
reported in the states of Hidalgo, Guerrero, Veracruz, 
Yucatán, Campeche, Tabasco, México, Oaxaca and Chiapas 
(Andrade-Cetto and Heinrich, 2005). The dried leaves (~15 
g) are boiled in water (~500 ml), and the resulting infusion 
should be cooled and then filtered, to drink it throughout 
the day as “agua de uso” (Andrade-Cetto and Heinrich, 
2005). The inhabitants of the community of Tlanchinol in 
the state of Hidalgo also use the tree bark for the treatment 
of the same disease (Andrade-Cetto, 1999). Furthermore, 
infusion of C. obtusifolia is used for the treatment of 
nerve conditions, as fever reducer (antipyretic), cardiac 
conditions, liver and pulmonary diseases, asthma, flu, 
wounds, scorpion and ant bites, bone fractures, kidneys, 
rheumatoid arthritis and wart removal, among many others 
(CONABIO, 2017).
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Figure 2: Guarumbo (Cecropia obtusifolia Bertol). Photo by J. D. Cadena-Zamudio, from a plant growing in the “Los Tuxtlas” Tropical Biology Station-
UNAM, San Andrés Tuxtla, Veracruz, Mexico.
Chemical compounds reported in Cecropia 
obtusifolia
Due to the properties mentioned above, some studies have 
been carried out to ascertain its chemical composition, the 
presence of sterols, tannins and monosaccharides, e.g., 
L-rhamnose, D-glucose and D-xylose was demonstrated; 
the presence of saponins and phenolics has also been re-
ported, as well as the absence of alkaloids, flavonols and 
cardiotonic glycosides (Trejo, 1983). Recent studies report-
ed the presence of 18 new compounds identified from C. 
obtusifolia leaves (Table 1), which have been shown to have 
both antidiabetic and anti-inflammatory activities.
Biological activity of the main phytochemicals 
identified in Cecropia obtusifolia
As mentioned above, different parts like leaves and tree 
bark of C. obtusifolia are used to treat various illnesses, 
mainly DM-2; the hypoglycemic effect was attributed to 
two secondary metabolites in particular, chlorogenic acid 
(CGA) and isoorientin (ISO) (Andrade-Cetto and Wieden-
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Table 1: Compounds identified in Cecropia obtusifolia Bertol. and its potential biological activities. DCME: dichloromethane extract; NR: not reported 
or very low concentrations. Modified from Rivera-Mondragón et al. (2017).
Compound Part of the plant Concentration Biological activity References
4,22-Cholestadien-3-one leaves DCME NR Guerrero et al. (2010)
4-Cholestene-3,24-dione leaves DCME NR Guerrero et al. (2010)
β-Sitosterol leaves NR Anti-inflammatory Andrade-Cetto and Heinrich (2005); Loizou et al. (2010)
Stigmast-4-en-3-one leaves DCME Anti-inflammatory, 
Anti-diabetic
Jamaluddin et al. (1995); Alexander-Lindo et al. (2004); 
Guerrero et al. (2010); Tewtrakul et al. (2010)
Stigmasterol leaves NR Anti-inflammatory Andrade-Cetto and Heinrich (2005); Gabay et al. (2010)
Aloe-emodin leaves NR Anti-inflammatory Choi et al. (2013); Yan et al. (2013); Kshirsagar et al. 
(2014); Park et al. (2016)
Chrysophanol leaves NR Anti-inflammatory Choi et al. (2013); Yan et al. (2013); Kshirsagar et al. 
(2014); Park et al. (2016)
Emodin leaves NR Anti-inflammatory Choi et al. (2013); Yan et al. (2013); Kshirsagar et al. 
(2014); Park et al. (2016)
Physcion leaves NR Anti-inflammatory Choi et al. (2013); Yan et al. (2013); Kshirsagar et al. 
(2014); Park et al. (2016)
Rehin leaves NR Anti-inflammatory Choi et al. (2013); Yan et al. (2013); Kshirsagar et al. 
(2014); Park et al. (2016)
1-(2-Methyl-1-nonen-8-il)-
aziridine leaves NR NR Andrade-Cetto and Heinrich (2005)
2-Methylbenzaldehyde leaves DCME NR Guerrero et al. (2010)
2,3-Dihydrobenzofuran leaves DCME NR Guerrero et al. (2010)
3´-Methoxyacetophenone leaves DCME NR Guerrero et al. (2010)
4-Ethyl-5-(n-3valeroil)-6-
hexahydrocoumarin
leaves NR NR Andrade-Cetto and Heinrich (2005)
4-Vinyl-2-methoxy-phenol leaves DCME NR Guerrero et al. (2010)
Palmitic acid leaves DCME Anti-inflammatory Guerrero et al. (2010)
Stearic acid leaves DCME Anti-inflammatory Guerrero et al. (2010); Pan et al. (2010)
feld, 2001), due to the stimulation in the glucose uptake 
2-NBD and the inhibition of glucose-6-phosphatase, result-
ing in an inhibition of the production of hepatic glucose and 
increase in the tolerance to glucose (Hemmerle et al., 1997; 
Andrade-Cetto and Wiedenfeld, 2001).
Pharmacological studies
Pérez et al. (1984) tested the hypoglycemic effect of C. ob-
tusifolia in mice with induced diabetic with Alloxan (tox-
ic compound that acts on the islets of Langerhans, used in 
experiments to induce diabetes mellitus in animal models). 
The same hypoglycemic effect was subsequently observed 
in hyperglycemic rabbits (Román-Ramos et al., 1991). In 
1997, Hemmerle et al. tested the effect of CGA and its deriv-
atives in the microsomal activity of glucose 6-phosphatase, 
demonstrating inhibition of glycogenolysis, gluconeogene-
sis, and reduction of liver glucose production. Andrade-Cetto 
and Wiedenfeld (2001) carried out studies on diabetic rats 
induced with STZ and treated with C. obtusifolia aqueous 
and butanolic extracts at doses of 90 mg/kg and 150 mg/kg 
for the first one, and 9 mg/kg and 15 mg/kg for the second 
one, finding a significant decrease in plasma glucose levels 
three hours after treatment. Sezik et al. (2005) showed that 
ISO, administered by oral route for two weeks in diabetic rats 
induced with STZ, decreased their glucose, cholesterol and 
triglycerides levels from the fifth day of treatment, keeping 
it up to 12 days after the suspension of the administration 
of the compound. Nicasio-Torres et al. (2005) reported con-
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centrations of 19.84±1.64 mg of CGA/g in the dry leaves of C. 
peltata and C. obtusifolia; the extract of the last one showed 
a decrease in plasma glucose levels (45.6%) between two 
and four hours after the oral administration. This proved that 
the hypoglycemic effect is correlated with the CGA concen-
trations in plant leaves. Andrade-Cetto et al. (2008) showed 
that the butanolic extract of C. obtusifolia leaves decreases 
the postprandial hyperglycemia in rats pre-treated with STZ; 
this effect was associated with the intestinal α-glucosidase 
enzyme inhibition, thus preventing the splitting of complex 
carbohydrates and delaying the absorption of glucose. Sim-
ilarly, Alonso-Castro et al. (2008), reported that the CGA is 
able to stimulate the production of glucose in sensitive and 
insulin resistant adipocytes. In 2010, Andrade-Cetto and 
Cárdenas Vázquez found that the mechanism of the hypo-
glycemia effect of C. obtusifolia is due to the inhibition of 
the enzyme glucose 6-phosphatase in the gluconeogenesis, 
which results in a reduction in the production of hepatic glu-
cose. Sezik et al., in 2005, reported the hypoglycemia and 
hypolipidemic effects of ISO in STZ-induced diabetic rats, 
dosing orally for two weeks, demonstrating that ISO can re-
duce the levels of glucose, cholesterol, and triglycerides from 
the fifth day of treatment and hold it up to ten days after the 
suspension of the treatment.
Toxicological studies
In the toxicological studies, Pérez-Guerrero et al. (2001) quan-
tified the lethal dose (LD50) in rats, using the aqueous extract 
of C. obtusifolia leaves and continued to administer intraper-
itoneally, obtaining a dose of 1.45±0.07 g/kg (equivalent to 
11.21±0.52 g/kg of dry leaf per body weight). Another study 
of this type, but with a genotoxic approach, was carried out 
by Martínez-Toledo et al. (2008), evaluating the possible ef-
fects of the aqueous extract of C. obtusifolia in somatic mu-
tation tests in Drosophila melanogaster Meigen wings and a 
micronucleus assay in lymphocytes obtained from patients 
treated with the extract; the results obtained did not show 
genotoxic or cytotoxic effects caused by the extract.
Clinical studies
There are some interesting data about clinical studies that 
involved the antidiabetic effects of C. obtusifolia. For exam-
ple, the study done by Herrera-Arellano et al. (2004) car-
ried out a double-blind design with uncontrolled diabetic 
patients between 30 and 60 years. Patients were provided 
with tea bags from C. obtusifolia leaves to prepare the in-
fusions with an oral dose of 2.99±0.14 mg/g of CGA before 
each meal. The length of the treatment was 21 days and 
showed that glucose (15.25%), cholesterol (14.62%) and 
triglycerides blood levels (42%) decreased with respect to 
the control group. A similar study was carried out by Re-
villa-Monsalve et al. (2007), in which they took diabetic 
patients without pre-treatment with conventional oral hy-
poglycemic drugs, and they were treated with infusions of 
C. obtusifolia leaves using concentrations of CGA=2.91 mg 
and ISO=2.4 mg; the patients displayed a significant reduc-
tion in glycosylated hemoglobin (HbA1c) after six weeks, 
without finding significant changes in the patient’s insulin 
secretion, nor in alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) and alkaline phosphatase (ALKP) 
levels; indicating no hepatotoxicity during the treatment.
Other biological activities
In this respect, antihypertensive effects are identified; 
since Salas et al. (1987) reported a drop-in blood pressure 
(-23.5% with respect to pre-injection values) in rats with 
consistent hypertension, when they were administered 
the lyophilized aqueous extract from leaves. In the same 
way, analgesic and anti-inflammatory effects have been re-
ported (Pérez-Guerrero et al., 2001). This justifies its use in 
different pathologies such as inflammatory, rheumatic and 
renal ones, which can also be associated with DM-2 symp-
toms and its complications.
Discussion and Conclusions
In Mexico, there is an extensive variety of treatments based 
on medicinal plants (phytomedicines). All these plants are 
part of the traditional Mexican herbalism, comprehending 
around 3000 species. Due to this abundant species num-
ber, Mexico is positioned as one of the world’s most im-
portant countries regarding the number of registered and 
used medicinal plants (Barragán, 2006). In both developed 
and developing countries, the use and commercialization 
of phytomedicines and natural products for medicinal pur-
poses has grown in recent years. In addition, it is import-
ant to note that due to the immense diversity of possible 
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bioactive molecules present in plants, there is currently an 
increase of patent protected allopathic medicines which 
are from plant origin. Due to this, the production of sec-
ondary metabolites using plant cell cultures, the generation 
of knowledge about the biosynthetic pathways and the en-
zymes involved, their functions in the host and the influ-
ence of environmental conditions in their synthesis are only 
some of the niches of opportunities for investigative work.
In the particular case of C. obtusifolia, despite its rel-
evance and potential at the pharmacological level, there 
are no genetic or genomic data for this species and, for ex-
ample, it is unknown whether orthologous genes already 
reported in other plant species are also responsible for the 
synthesis of interesting metabolites such as chlorogenic 
acid and isoorientin. In addition, the questions are how dif-
ferent metabolic pathways modulate the synthesis of ac-
tive molecules and how these affect the synthesis of these 
molecules remain unanswered (Wang et al., 2009). Most 
of the specialized metabolites of interest are produced in 
non-model plants for which genomic/transcriptomic se-
quence information is not yet available. Fortunately, NGS 
(Next Generation Sequences) technologies can be imple-
mented to sequence plant transcriptomes from medicinal 
plants (Morozova et al., 2009; Fonseca et al., 2016). The 
massive gene lists that can be generated thus represent a 
seemingly unlimited catalog of enzymes, transporters, or 
regulators to be used in synthetic biology programs (Ozso-
lak and Milos, 2011). This wealth of sequences has shifted 
the paradigm in gene discovery quests, which no longer 
focus on the isolation of candidate plant gene sequences, 
but rather on how to find the right one in the immensity 
of duplicated and neofunctionalized genes, which through 
evolution have resulted in hundreds of thousands of differ-
ent specialized metabolites that can be found in the plant 
kingdom (Saito and Matsuda, 2010). If sequence assembly 
is complemented with extensive in silico analysis, a (tenta-
tive) functional annotation can be assigned and then this 
information can be used to reconstruct metabolic pathways 
and discover missing enzymes in the pathways (Metzker, 
2010; Garber et al., 2011; Fonseca et al., 2016).
Besides gene sequences, metabolic pathways con-
struction will heavily depend on metabolomics for valida-
tion (Saito and Matsuda, 2010). Plants are challenging in 
this regard as a single plant (cell) can harbor thousands 
of metabolites, many of whose structure is yet unknown. 
Plant metabolomics will require both targeted and non 
targeted analysis, within which high resolution mass spec-
trometry based techniques, along with nuclear magnetic 
resonance spectroscopy, will be most suitable because of 
the remaining need for the annotation of unknown com-
pounds (Saito and Matsuda, 2010; Soda et al., 2015; Mo-
chida and Shinozaki, 2017). Here, we propose C. obtusifolia 
as a “non-model” plant species which should be used for, 
by the systematic integration of transcriptomics and me-
tabolomics, investigating the molecular basis of the synthe-
sis and function of some metabolites, mainly from those 
which have potential to treat important diseases.
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